Success Metrics

Completion Rate

0%(0/2)

Active Trials

5(56%)

Terminated

2(22%)

Phase Distribution

Ph not_applicable

22%

Ph phase_2

11%

Ph early_phase_1

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Terminated(3)

Detailed Status

Recruiting3

Terminated2

Active, not recruiting2

Enrolling by invitation1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (25.0%)

Phase 21 (25.0%)

N/A2 (50.0%)

Trials by Status

enrolling_by_invitation111%

recruiting333%

terminated222%

withdrawn111%

active_not_recruiting222%

Recent Activity

5 active trials

Showing 5 of 9

active_not_recruiting

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

NCT02611180

terminated

Role of Insulin Action in Psoriasis Pathogenesis

NCT06242847

recruitingphase_2

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

NCT05535738

active_not_recruitingearly_phase_1

Evaluating the Human Immune Response to the JYNNEOS Vaccine

NCT06366672

recruiting

DERMATOMICS: Identifying Regulators of Skin Homeostasis

NCT06894654

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT02611180

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Active Not Recruiting

NCT06242847

Role of Insulin Action in Psoriasis Pathogenesis

Terminated

NCT05535738Phase 2

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting

NCT06366672Early Phase 1

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Active Not Recruiting

NCT06894654

DERMATOMICS: Identifying Regulators of Skin Homeostasis

Recruiting

NCT02772367

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Recruiting

NCT06711510Not Applicable

Predict to Prevent PGRN Disease

Withdrawn

NCT06371794Not Applicable

EXploring novEl Molecular Determinants of DRAvet Syndrome Phenotype Heterogeneity

Enrolling By Invitation

NCT01466504

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Terminated

All 9 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 9